By Howard Wolinsky
TheActiveSurveillor.com is focused on low-risk prostate cancer. But, when we can, we keep an eye out on our “bothers” at the other end of the spectrum—men with advanced prostate cancer, which kills about 35,000 American men a year and 375,000 men worldwide. It’s the second most common cancer killer in men after lung cancer.
The hope is that we maintain our vigilance to try to detect PCa early and to surveil or treat as needed to try to stop cancer before it becomes dangerous.
Another big name has died from PCa.
A.J. Smith, the winningest general manager in Los Angeles Chargers history, died from prostate cancer, his family announced Sunday. He was 75.
"Belying a tough, matter of fact and no-nonsense persona – one synonymous with that of a true football guy – was A.J.’s softer side, which included a tremendous love for his family, the NFL, and the Chargers. The architect of one of the greatest chapters in franchise history, A.J. made everyone around him better with a singular focus and intensity that elevated our organization," Chargers owner and board chair Dean Spanos said in a statement.
Last month, PCa took another life of a prominent (and notorious) NFL-er: O.J. Simpson, 76, whose name was well known beyond the NFL, as an actor and for his involvement in trials for allegedly murdering his ex-wife and her friend.
BREAKING News!! O.J. dead from PCa
By Howard Wolinsky The murder charge against O.J. Simpson hit the public consciousness on June 17, 1994 with a two-hour slow chase on SoCal freeways. The police armed with an arrest warrant were in pursuit of white Ford Bronco. The 30-year chase through Simpson’s notorious has ended with his death, apparently from prostate cancer.
Join the patient’s ‘Journal Club‘ at UCSF May 14
Matthew Cooperberg, MD, MPH, an Active Surveillance champion, is holding a pioneering free “journal club: where patients can hear leading researches dfiscuss their work and ask questions. The next session is at 5 pm Eastern May 14. Register here: https://tinyurl.com/4tamfuuk
“A traditional journal club involves a group of docs ± trainees reading cutting-edge papers and discussing their strengths and limitations and implications for research/practice,” Cooperberg told The ACtive Surveillor.
He added: “The Prostate Cancer Journal Club for Patients presents recent, game-changing medical papers while avoiding medical jargon and focusing on direct impact on patients’ treatments. The purpose is to educate patients to help them make better-informed decisions about their prostate cancer care in collaboration with their doctors.”
The next session is entitled “PSA rising after prostatectomy and/or radiation therapy for prostate cancer?” and covers the practice-changing finding, from the EMBARK clinical trial.
Lead investigators Stephen J. Freedland, MD, and Neal D. Shore, MD, will be featured with commentary by Rana McKay, MD.
PCa—not just for old men: Join ASPI webinar on May 25
Prostate cancer typically is diagnosed in men in their late 60s. It’s considered a disease of aging, an old man’s disease.
But Gabe Canales tells a different story.
He was diagnosed when he was 35. At an upcoming webinar for Active Surveillance Patients International (ASPI), Canales will share his prostate cancer experience and how it can help you and your sons and grandsons.
The webinar will be at noon Eastern Saturday, May 25. Register Here: https://tinyurl.com/3sexhrrp
(Gabe Canales, of Blue Cure, https://bluecure.org/)
Was a recording made of yesterday's UCSF Journal Club available for rebroadcast
in days?